The uncontrolled activation of the ALK-kinase defines a phosphoproteomic and transcriptional signature that drives the oncogenic program of ALK+ ALCL cases (42–44), and ALK+ ALCL constitutes a specified entity. Here, ALK is linked to anaplastic large cell lymphoma.